How have BPCR shares performed in 2024?

BioPharma Credit's stock was trading at GBX 0.84 at the beginning of the year. Since then, BPCR stock has increased by 4.3% and is now trading at GBX 0.88. View the best growth stocks for 2024 here .

How often does BioPharma Credit pay dividends? What is the dividend yield for BioPharma Credit?

BioPharma Credit announced a dividend on Thursday, March 21st. Shareholders of record on Thursday, March 28th will be paid a dividend of GBX 0.02 per share on Tuesday, April 30th. This represents a yield of 1.97%. The ex-dividend date of this dividend is Thursday, March 28th. The official announcement can be viewed at this link . Read our dividend analysis for BPCR .

Is BioPharma Credit a good dividend stock?

BioPharma Credit (LON:BPCR) pays an annual dividend of GBX 7 per share and currently has a dividend yield of 8.47%. BPCR has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 5,384.62%. Payout ratios above 75% are not desirable because they may not be sustainable. Read our dividend analysis for BPCR .

What other stocks do shareholders of BioPharma Credit own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioPharma Credit investors own include AFPO.L (AFPO) , Altius Minerals (ATUSF) , LiDCO Group Plc (LID.L) (LID) , 21512 (SAT.L) (SAT) , San Juan Basin Royalty Trust (SJT) , ANGLE (AGL) , Hochschild Mining (HOC) , SPX FLOW (FLOW) , Fulcrum Utility Services (FCRM) and DX (Group) (DX) .

How do I buy shares of BioPharma Credit?

Shares of BPCR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:BPCR

BioPharma Credit (BPCR) Share Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free BPCR Stock Alerts

GBX 0.88

0.00 (0.00%)

(As of 04/19/2024 ET)

Compare

Today's Range: 0.87
▼
0.88
50-Day Range: 0.87
▼
0.93
52-Week Range: 0.81
▼
0.97

Volume: 2.40 million shs
Average Volume: 1.86 million shs
Market Capitalization: £11.39 million

P/E Ratio: 6.74
Dividend Yield: 799.09%
Price Target: N/A

Stock Analysis Chart Competitors Dividend Headlines Insider Trades

Get BioPharma Credit alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About BioPharma Credit Stock (LON:BPCR)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.

BPCR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BPCR Stock News Headlines

March 28, 2024 | insidertrades.com

Sapna Shah Acquires 20,000 Shares of BioPharma Credit (LON:BPCR) Stock

February 26, 2024 | nz.finance.yahoo.com

BioPharma Credit PLC (BPCP.L)

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

February 22, 2024 | finance.yahoo.com

Investors in BioPharma Credit (LON:BPCR) have seen notable returns of 40% over the past five years

February 7, 2024 | realmoney.thestreet.com

Biopharma Credit just downgraded at Jefferies, here's why

January 9, 2024 | markets.businessinsider.com

Assessing Ambrx Biopharma: Insights From 7 Financial Analysts

January 8, 2024 | finance.yahoo.com

BioPharma Credit Ord (BPCR.L)

January 2, 2024 | lse.co.uk

BioPharma Credit to fund LumiraDx ahead of acquisition by Roche

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

December 3, 2023 | finance.yahoo.com

BioPharma Credit PLC (LON:BPCR) Looks Interesting, And It's About To Pay A Dividend

October 4, 2023 | msn.com

Truist Securities Downgrades POINT Biopharma Global (PNT)

September 19, 2023 | lse.co.uk

BioPharma Credit notes liquidity amendments to LumiraDX loan deal

September 12, 2023 | benzinga.com

Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update

August 27, 2023 | finance.yahoo.com

Investing in BioPharma Credit (LON:BPCR) five years ago would have delivered you a 19% gain

August 24, 2023 | finanznachrichten.de

LumiraDx Inc: LumiraDx Reports Second Quarter 2023 Results

August 16, 2023 | forbes.com

Best Credit Cards For Recent College Graduates In August 2023

August 2, 2023 | marketwatch.com

ABVC Biopharma Shares Drop 15% After Big Rise Tuesday

July 25, 2023 | msn.com

Cantor Fitzgerald Maintains Reata Pharmaceuticals Inc - (RETA) Overweight Recommendation

July 23, 2023 | forbes.com

Best Mobile Credit Card Readers Of 2023

July 6, 2023 | msn.com

TD Cowen Initiates Coverage of Reata Pharmaceuticals Inc - (RETA) with Outperform Recommendation

June 26, 2023 | msn.com

DRI Healthcare Trust says CTI BioPharma repaid $54.8M debt

June 21, 2023 | cnbc.com

This stock could become a 'one-stop shop' for biopharma and rally more than 35%, RBC says

May 3, 2023 | msn.com

Hear how Cambrian BioPharma is reinventing drug (and drug company) development

April 23, 2023 | finance.yahoo.com

BioPharma Credit PLC (LON:BPCR) Passed Our Checks, And It's About To Pay A US$0.018 Dividend

March 20, 2023 | finance.yahoo.com

BioPharma Credit's (LON:BPCR) investors will be pleased with their notable 42% return over the last three years

March 13, 2023 | marketwatch.com

Ambrx Biopharma Shares Rise 7% After Completing ATM Program

February 19, 2023 | msn.com

The next big wave of patent cliffs is ahead; expect biopharma M&A to rise – report

See More Headlines

Receive BPCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/15 Dividend: 2/15/2024
Dividend Payable: 3/15/2024
Ex-Dividend for 4/30 Dividend: 3/28/2024
Today: 4/19/2024
Dividend Payable: 4/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Financial Services
Industry: Asset Management
Sub-Industry: N/A
Current Symbol: LON:BPCR
CUSIP: N/A
CIK: N/A
Web: www.bpcruk.com
Phone: 44 13 9247 7500
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX 0.13
Trailing P/E Ratio: 6.74
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £185.07 million
Net Margins: 83.84%
Pretax Margin: N/A
Return on Equity: 13.65%
Return on Assets: 8.50%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 21.75
Quick Ratio: 14.07

Sales & Book Value

Annual Sales: £220.74 million
Price / Sales: 0.05
Cash Flow: GBX 0.73 per share
Price / Cash Flow: 1.19
Book Value: GBX 102 per share
Price / Book: 0.01

Miscellaneous

Outstanding Shares: 1,300,000,000
Free Float: N/A
Market Cap: £11.39 million
Optionable: Not Optionable
Beta: 0.21

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Pedro Gonzalez de Cosio
Investment Manager
Mr. Pablo Gerardo Legorreta (Age 59)
Investment Manager
Mr. Martin G. Friedman (Age 58)
Investment Manager

Key Competitors

View All Competitors

Insiders

Sapna Shah
Bought 20,000 shares on 3/27/2024
Total: £1.44 M ($72.00/share)

View All Insider Transactions

BPCR Stock Analysis - Frequently Asked Questions

How have BPCR shares performed in 2024?: BioPharma Credit's stock was trading at GBX 0.84 at the beginning of the year. Since then, BPCR stock has increased by 4.3% and is now trading at GBX 0.88.
View the best growth stocks for 2024 here.
How often does BioPharma Credit pay dividends? What is the dividend yield for BioPharma Credit?: BioPharma Credit announced a dividend on Thursday, March 21st. Shareholders of record on Thursday, March 28th will be paid a dividend of GBX 0.02 per share on Tuesday, April 30th. This represents a yield of 1.97%. The ex-dividend date of this dividend is Thursday, March 28th. The official announcement can be viewed at this link.
Read our dividend analysis for BPCR.
Is BioPharma Credit a good dividend stock?: BioPharma Credit (LON:BPCR) pays an annual dividend of GBX 7 per share and currently has a dividend yield of 8.47%. BPCR has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 5,384.62%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for BPCR.

What other stocks do shareholders of BioPharma Credit own?: Based on aggregate information from My MarketBeat watchlists, some companies that other BioPharma Credit investors own include AFPO.L (AFPO), Altius Minerals (ATUSF), LiDCO Group Plc (LID.L) (LID), 21512 (SAT.L) (SAT), San Juan Basin Royalty Trust (SJT), ANGLE (AGL), Hochschild Mining (HOC), SPX FLOW (FLOW), Fulcrum Utility Services (FCRM) and DX (Group) (DX).
How do I buy shares of BioPharma Credit?: Shares of BPCR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:BPCR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial